0300 111 5555 Donate Dementia information How you can help Research About us Work for us Home > About us > Work for us Join the UK’s leading dementia research charity, Alzheimer’s Research UK. View our job vacancies Our location Find out what’s in our local area. What’s in it for you? We use cookies to give you the best possible experience on our websites. Some are necessary to make our sites work, and others help us to personalise content and tailor advertising. These are stored on your device and are placed by us and trusted partners. OK, continue to site Find out more

0300 111 5555 Donate Dementia information How you can help Research About us For commissioners Home > About us > Policy and influence > For commissioners Resources for commissioners and the wider health sector to support dementia service provision in the UK. We use cookies to give you the best possible experience on our websites. Some are necessary to make our sites work, and others help us to personalise content and tailor advertising. These are stored on your device and are placed by us and trusted partners. OK, continue to site Find out more

0300 111 5555 Donate Dementia information How you can help Research About us BLOG Answering your questions about aducanumab 20 August 2021 - Comments Off on Answering your questions about aducanumab « Back to all blogs In June 2021, the United States Food and Drug Administration (FDA) made a landmark decision to approve the Alzheimer’s drug aducanumab (known commercially as Aduhelm). Although we are still waiting to learn whether aducanumab will be granted similar approval for use in the UK, this is the first time a drug has been approved for dementia treatment in nearly 20 years. We use cookies to give you the best possible experience on our websites. Some are necessary to make our sites work, and others help us to personalise content and tailor advertising. These are stored on your device and are placed by us and trusted partners. OK, continue to site Find out more

0300 111 5555 Donate Dementia information How you can help Research About us How we fund research Home > Research > About our research > How we fund research Alzheimer’s Research UK is dedicated to making life-changing breakthroughs in diagnosis, prevention, treatment and cure. Through investing in research, we will help make these breakthroughs possible. To make sure that we fund the highest quality projects with the best chance of success, we have a thorough peer review process which follows guidelines set out by the Association of Medical Research Charities. We use cookies to give you the best possible experience on our websites. Some are necessary to make our sites work, and others help us to personalise content and tailor advertising. These are stored on your device and are placed by us and trusted partners. OK, continue to site Find out more